<DOC>
	<DOCNO>NCT00764257</DOCNO>
	<brief_summary>The purpose study ass PREVELLE Shape ( CX002 ) , respect safety efficacy one year follow treatment , correction facial nasolabial fold apply intradermal implant lip augmentation .</brief_summary>
	<brief_title>PREVELLE Shape ( CX002 ) Dermal Filler Protocol</brief_title>
	<detailed_description />
	<criteria>Inclusion Criteria 1 . Subjects give write informed consent participate . 2 . Male female subject age 30 60 year inclusive ( nasolabial fold cohort ) male female subject 18 year age old ( lip augmentation cohort ) . 3 . Subjects NLFs shallow wrinkle , moderately deep wrinkle , deep wrinkle well define edge ( level 2 , 3 , 4 sixpoint categorical rating scale ) , suitable soft tissue augmentation subject desire lip enlargement . Exclusion Criteria 1 . Subjects unwilling unable give write consent participate investigation unable comply requirement protocol . 2 . Subjects know hypersensitivity sodium hyaluronate , lidocaine , xylocaine , epinephrine . 3 . Subjects know severe allergy manifest history anaphylaxis , history presence severe multiple allergy . 4 . Subjects serious skin disease , e.g. , Eczema psoriasis face , severe rosacea , scleroderma , local infection severe acne . 5 . Subjects cancerous precancerous lesion either right left NLF lips . 6 . Subjects diabetes , coagulation disorder , connective tissue disorder , lipodystrophy , serious systemic disease . 7 . Subjects active herpes labialis . 8 . Subjects infect HIV and/or receive immunosuppressive therapy . 9 . Subjects receive injection resorbable tissue augmentation material NLFs lip within 18 month prior baseline . 10 . Subjects receive permanent tissue implant material NLFs lip . 11 . Subjects receive experimental drug device within previous three month . 12 . Subjects undergo another facial aesthetic procedure ( include surgical , dermal implantation , Botox treatment , dermabrasion , facial massage , photoaging treatment e.g. , RetinA relate cream ) , entire 12month study period 13 . Subjects undergo major facial plastic surgery ( e.g . rhinoplasty without implant , eyelid lift , facelift , etc ) . 14 . Subjects know alcohol drug abuser . 15 . Female subject pregnant lactate intend become pregnant period study , would use adequate method contraception ( contraceptive pill , intrauterine device ) duration study . 16 . Possessed psychological condition , treatment condition , opinion Investigator and/or consult physician ( ) , would constitute unwarranted risk . 17 . Worked Mentor study Investigator directlyrelated anyone work Mentor study doctor . 18 . Subjects require facial soft tissue augmentation traumatic injury ( nasolabial fold cohort ) . 19 . Subjects none , perceptible deep nasolabial wrinkle ( 0 , 1 , , 5 point sixpoint Lemperle rating scale ) ( nasolabial fold cohort ) . 20 . Subjects treat RetinA four week prior baseline visit ( nasolabial fold cohort ) . 21 . Subjects treat Botox anywhere face within six month prior baseline visit ( nasolabial fold cohort ) . 22 . Subjects receive laser resurface anywhere face within 12 month prior baseline visit ( nasolabial fold cohort ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
</DOC>